Company News

Company News
November 18, 2022
Core One Labs’ Prepares for Commercial Production of API-Grade Psilocybin; Plans Initial Production Run at GMP Facility in January
Vancouver, British Columbia, Canada – November 18, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
November 10, 2022
Core One Labs Announces Grant of Stock Options
Vancouver, British Columbia, Canada – November 10, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
November 09, 2022
Core One Labs Announces Grant of Restricted Share Units
Vancouver, British Columbia, Canada – November 9, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
October 21, 2022
Core One Labs Takes Next Steps to Prepare for Potential Takeover Opportunities
Vancouver, British Columbia, Canada – October 21, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
October 14, 2022
European University to Fund Core One Labs’ Akome Advanced Neurogenesis Stimulation Studies
Vancouver, British Columbia, Canada – October 14, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
October 07, 2022
Core One Labs Nearing GMP Production as Canada’s Province of Alberta Announces Game Changing Legislation
Vancouver, British Columbia, Canada – October 7, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the...
Read more